Group One Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-87,500
| Closed | -$1.31M | – | 8364 |
|
|
2022
Q4 | $1.31M | Sell |
87,500
-22,500
| -20% | -$312K | ﹤0.01% | 2187 |
|
|
2022
Q3 | $905K | Sell |
110,000
-28,800
| -21% | -$221K | ﹤0.01% | 2673 |
|
|
2022
Q2 | $911K | Buy |
138,800
+47,200
| +52% | +$229K | ﹤0.01% | 2848 |
|
|
2022
Q1 | $512K | Sell |
91,600
-60,000
| -40% | -$247K | ﹤0.01% | 3788 |
|
|
2021
Q4 | $711K | Sell |
151,600
-45,600
| -23% | -$283K | ﹤0.01% | 3714 |
|
|
2021
Q3 | $1.22M | Buy |
197,200
+46,900
| +31% | +$281K | ﹤0.01% | 3197 |
|
|
2021
Q2 | $990K | Sell |
150,300
-41,100
| -21% | -$283K | ﹤0.01% | 3423 |
|
|
2021
Q1 | $1.4M | Sell |
191,400
-349,900
| -65% | -$3.02M | ﹤0.01% | 2843 |
|
|
2020
Q4 | $3.12M | Sell |
541,300
-21,000
| -4% | -$120K | 0.01% | 1669 |
|
|
2020
Q3 | $3.34M | Buy |
562,300
+10,200
| +2% | +$50.5K | 0.01% | 1198 |
|
|
2020
Q2 | $2.84M | Buy |
552,100
+267,600
| +94% | +$1.69M | 0.01% | 1214 |
|
|
2020
Q1 | $1.03M | Buy |
284,500
+112,570
| +65% | +$559K | 0.01% | 1497 |
|
|
2019
Q4 | $1.07M | Sell |
171,930
-19,210
| -10% | -$141K | 0.01% | 1814 |
|
|
2019
Q3 | $1.61M | Sell |
191,140
-50,600
| -21% | -$377K | 0.01% | 1376 |
|
|
2019
Q2 | $1.63M | Buy |
241,740
+36,780
| +18% | +$315K | 0.01% | 1239 |
|
|
2019
Q1 | $1.68M | Buy |
204,960
+31,370
| +18% | +$324K | 0.02% | 1049 |
|
|
2018
Q4 | $2.78M | Buy |
173,590
+95,500
| +122% | +$2.1M | 0.02% | 814 |
|
|
2018
Q3 | $2.58M | Buy |
78,090
+41,070
| +111% | +$1.06M | 0.02% | 978 |
|
|
2018
Q2 | $837K | Buy |
37,020
+22,600
| +157% | +$536K | 0.01% | 1879 |
|
|
2018
Q1 | $418K | Sell |
14,420
-15,140
| -51% | -$443K | ﹤0.01% | 2198 |
|
|
2017
Q4 | $825K | Sell |
29,560
-13,410
| -31% | -$416K | 0.01% | 1870 |
|
|
2017
Q3 | $1.57M | Buy |
42,970
+34,610
| +414% | +$1.07M | 0.01% | 1224 |
|
|
2017
Q2 | $186K | Buy |
8,360
+6,870
| +461% | +$54.1K | ﹤0.01% | 2694 |
|
|
2017
Q1 | $9K | Buy |
1,490
+1,190
| +397% | +$8.6K | ﹤0.01% | 4157 |
|
|
2016
Q4 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 4276 |
|
|
2013
Q3 | – | Sell |
-7,150
| Closed | -$179K | – | 5772 |
|
|
2013
Q2 | $179K | Buy |
+7,150
| New | +$306K | ﹤0.01% | 2283 |
|
Group One Trading's AVEO Position: Q1 2023 in Review
Group One Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 34,258 shares — an estimated $512K sold.
Group One Trading first reported a position in AVEO in Q2 2013 and held it in 19 quarters. The position peaked at $566K in Q2 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Group One Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 34,258 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $512K.
- Group One Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Group One Trading's AVEO Pharmaceuticals, Inc. position peaked at $566K in Q2 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.